DS
Daniel S. Lorrain sold $17K of CTNM stock
Daniel S. Lorrain, Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM), sold 1,040 shares of CTNM stock worth $17K, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 8, 2026, 2 days before it was made public.
CTNM has moved -42.2% since the trade date, from $15.65 to $9.04 (Nov 19, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 2 days
- Price since
- -42.2%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4